Lilly’s planning to file for US approval of one of the hottest drugs to hit the market in recent years. The problem? Scores of people are already taking knockoff versions. Stopping that might not be easy. https://t.co/JbDo0TX5fH ...

>> ALL RIGHT. WHAT HAPPENED TO THE STOCK IN NOVO NORDISK. THE DANISH DRUG COMPANY, YOU KNOW, IS THE INVENTOR OF OZEMPIC AND WEGOVY.LAST WEEK, THEY REPORTED A BEAT AND RAISE QUARTER. YET THE STOCK FELL NEARLY 6% THE DAY THOSE NUMBERS WERE RELEASED. SINCE THEN, WELL, IT MADE UP MOST OF ITS LOSSES, BUT THAT WAS A STUNNING REACTION.HEY, KEEP IN MIND, NOVO NORDISK HELPED INVENT THE GLP ONE CATEGORY, AND THEIR OBESITY AND DIABETES BUSINESSES ARE NOW PRINTING MONEY. IN JANUARY, THEY LAUNCHED A PILL VERSION OF WEGO ...

Eli Lilly has filed six new lawsuits against U.S. “medical spas” and “wellness clinics” that it alleges are selling a version of the company’s investigational weight-loss drug retatrutide on the black market. https://t.co/YCKxqFvyk9 ...

Macroeconomic Trends - US consumer prices rose 0.1% in July, bringing the annual inflation rate to 3.4% as gasoline and grocery prices fell [1] - The US economy unexpectedly lost 23,000 jobs in the previous month, intensifying affordability challenges for first-time home buyers amidst a cooling labor market [2] - The USDA increased its projections for US corn and soybean output in its August report due to higher planted acreage [8] Corporate & Technology Sector - Wendy's shares surged following reports of Nelson Peltz's Trian Fund Management preparing a take-private bid and adding 0.07% to its holdings [3] - Nvidia announced a $500 billion artificial intelligence financing initiative to accelerate AI development and adoption [4] - Nebius reported a 514% jump in AI cloud sales driven by robust demand and Nvidia's massive funding plan [5] - Bank of America announced a $250 billion investment plan to modernize US infrastructure targeting critical sectors nationwide [6] - Cisco Systems reported better than expected quarterly earnings and raised its fiscal 2027 revenue outlook, with analysts estimating earnings per share of $0.87 and revenue of $16.8 billion [9][10]

This Billionaire Made $360 Million Selling His Psychedelic Company To Eli LillyTwelve years ago, Christian Angermayer took a mushroom trip that inspired him to try to create FDA-approved medicines from psychedelic drugs. Now Big Pharma is making a $2.8 billion bet on his vision. https://t.co/0HHk4FASMH ...